Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 13/20 | 0.58 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.58 |
| ▸ | SMPD1 | P17405 | 5/20 | 0.52 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4638947 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL7188409 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL2695072 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL1044717 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL62052 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL418810 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL2693656 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL632447 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL905578 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL60424 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9606126-B2 | Compositions and methods for membrane protein detergent stability screen | UNIVERSITY OF VIRGINA PATENT FOUNDATION (US) | 2017-03-28 | — | — | US | claimed |
| US-9513253-B2 | Droplet actuators and techniques for droplet-based enzymatic assays | ADVANCED LIQUID LOGIC, INC. (US) | 2016-12-06 | — | — | US | claimed |
| US-20140246319-A1 | DROPLET ACTUATORS AND TECHNIQUES FOR DROPLET-BASED ASSAYS | ADVANCED LIQUID LOGIC, INC. (US) | 2014-09-04 | — | — | US | claimed |
| WO-2013009927-A2 | DROPLET ACTUATORS AND TECHNIQUES FOR DROPLET-BASED ASSAYS | ADVANCED LIQUID LOGIC, INC. (US) | 2013-01-17 | — | — | WO | claimed |
| WO-2005007895-A1 | METHODS AND KITS FOR OBTAINING NUCLEIC ACID FROM BIOLOGICAL SAMPLES | APPLERA CORPORATION (US) | 2005-01-27 | — | — | WO | claimed |
| US-20050009036-A1 | Methods and kits for obtaining nucleic acid from biological samples | APPLERA CORPORATION (US) | 2005-01-13 | — | — | US | claimed |
| US-12577543-B2 | Method for producing polyisoprenoid by reaction catalyzed by mutant cis-prenyltransferase (CPT) family protein, and method for producing rubber product | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2026-03-17 | — | — | US | disclosed |
| US-20260071031-A1 | COMPOSTABLE CORE-SHELL PARTICLES FOR IMPACT MODIFICATION OF RIGID PLASTICS | UNIV IOWA STATE RES FOUND INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260002179-A1 | METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSFORMED PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2026-01-01 | — | — | US | disclosed |
| US-20250326814-A1 | MODIFIED OXYNTOMODULIN AND METHODS OF USE THEREOF | OPKO BIOLOGICS LTD. (IL) | 2025-10-23 | — | — | US | disclosed |
| US-12391964-B2 | Method for producing polyisoprenoid, vector, transformed plant, method for producing pneumatic tire, and method for producing rubber product | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2025-08-19 | — | — | US | disclosed |
| EP-1817048-B2 | STABLE FORMULATIONS OF INSULINOPTROPIC PEPTIDES | NOVO NORDISK AS (DK) | 2025-06-18 | — | — | EP | disclosed |
| EP-3586142-B1 | DETECTION OF MEMBRANE PROTEINS | UNIV OXFORD INNOVATION LTD (GB) | 2024-12-25 | — | — | EP | disclosed |
| US-20030061687-A1 | High throughput screening of crystallization materials | CALIFORNIA INSTITUTE OF TECHNOLOGY, A CALIFORNIA CORPORATION | 2003-04-03 | — | — | US | disclosed |
| WO-2002056831-A9 | IMMUNOGENIC PROTEOLIPOSOMES, AND USES THEREOF | DANA FARBER CANCER INST INC (US) | 2002-12-27 | — | — | WO | disclosed |
| WO-2002082047-A2 | HIGH THROUGHPUT SCREENING OF CRYSTALLIZATION OF MATERIALS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2002-10-17 | — | — | WO | disclosed |
| EP-1246607-A1 | PROTEOLIPOSOMES CONTAINING AN INTEGRAL MEMBRANE PROTEIN HAVING ONE OR MORE TRANSMEMBRANE DOMAINS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2002-10-09 | — | — | EP | disclosed |
| WO-2002056831-A2 | IMMUNOGENIC PROTEOLIPOSOMES, AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2002-07-25 | — | — | WO | disclosed |
| US-20010034432-A1 | Proteoliposomes containing an integral membrane protein having one or more transmembrane domains | DANA-FARBER CANCER INSTITUTE, INC. | 2001-10-25 | — | — | US | disclosed |
| WO-2001049265-A1 | PROTEOLIPOSOMES CONTAINING AN INTEGRAL MEMBRANE PROTEIN HAVING ONE OR MORE TRANSMEMBRANE DOMAINS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2001-07-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260002179-A1 | METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSFORMED PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT | FNTB, FNTA, TPT1 | FDPS 11/4885GGPS1 4/4885SMPD1 3050/4885 |
| US-20250326814-A1 | MODIFIED OXYNTOMODULIN AND METHODS OF USE THEREOF | OGFRL1, OXGR1, THOP1 | FDPS 3765/4885GGPS1 3921/4885SMPD1 3534/4885 |
| US-12577543-B2 | Method for producing polyisoprenoid by reaction catalyzed by mutant cis-prenyltransferase (CPT) family protein, and method for producing rubber product | FNTB, RTCB, PTAR1 | FDPS 247/4885GGPS1 10/4885SMPD1 3516/4885 |
| US-20260071031-A1 | COMPOSTABLE CORE-SHELL PARTICLES FOR IMPACT MODIFICATION OF RIGID PLASTICS | SBDS, COPE, DLST | FDPS 1364/4885GGPS1 1518/4885SMPD1 1937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.